DEFA14A: Life360 Seeks Stockholder Approval for Share Increase Amidst U.S. IPO Plans

Life360 is seeking stockholder approval to increase its authorized shares to facilitate a potential U.S. IPO and provide flexibility for future strategic transactions and equity incentives.

Summary

• Life360 is supplementing its proxy statement to provide additional information regarding Proposal 14, which seeks approval for an amendment to increase the number of authorized shares.
• The company is considering a U.S. IPO and believes increasing authorized shares will provide greater flexibility should favorable conditions arise.
• Currently, Life360 has approximately 4,984,060 shares (less than 5%) unreserved and available for future issuance out of 100,000,000 authorized shares.
• A U.S. IPO of US$100 million would exhaust substantially all of these unreserved shares.
• The company is requesting approval for 500,000,000 authorized shares, which is less than 1/5th of the average number of authorized shares for other newly public U.S. technology companies (estimated at over 2,600,000,000 shares).
• The company needs additional authorized shares for strategic transactions, equity incentives, and to maintain an evergreen provision in the Stock Plan.
• While incorporated in Delaware, Life360 notes that Australian-incorporated companies listed on the ASX do not have a share count limit.
• Even with the share increase, Life360 will still be subject to ASX Listing Rules and Nasdaq rules that provide separate restrictions on share issuances.
• The board recommends a vote in favor of Proposal 14.

Sentiment

Score: 7

Explanation: The document is generally positive, outlining strategic moves for growth and flexibility. However, there are inherent risks associated with IPOs and potential dilution, tempering the overall sentiment.

Positives

• Increasing authorized shares provides flexibility for a potential U.S. IPO.
• More shares allow for strategic transactions and equity incentives to attract and retain talent.
• The requested share increase aligns Life360 more closely with the practices of Australian-incorporated companies listed on the ASX.
• The company will still be subject to share issuance restrictions under ASX and Nasdaq rules, protecting stockholders.

Negatives

• A U.S. IPO could dilute existing shareholders if a secondary sale of existing shares is not sufficient.
• The company may be unable to pursue strategic acquisitions or partnerships without sufficient authorized shares.

Risks

• The U.S. IPO is not guaranteed and depends on market conditions.
• Failure to obtain stockholder approval for the share increase could limit the company's strategic options.
• Increased authorized shares could lead to future dilution if not managed carefully.

Future Outlook

The company is considering a U.S. IPO, but the timing, number of shares, and pricing are yet to be determined and depend on market conditions. The company believes increasing authorized shares will provide greater flexibility to pursue a potential offering should favorable conditions arise.

Management Comments

• The Company, with headquarters in the San Francisco area and pre-existing SEC reporting obligations, views a U.S. IPO and increased exposure to U.S. investors as a natural next-step in its growth.
• The Board believes it is appropriate to increase our authorized shares of common stock to provide additional flexibility to promptly and appropriately use our common stock for strategic, business and financial purposes in the future, as well as to have sufficient shares available to provide appropriate equity incentives for our employees and other eligible service providers.

Industry Context

Many U.S. technology companies implement a higher authorized shares threshold at the time of an initial public offering, averaging over 2,600,000,000 shares. Life360's request for 500,000,000 authorized shares is less than 1/5th of this average. Australian incorporated companies listed on the ASX are not subject to a share count limit.

Comparison to Industry Standards

• Newly public U.S. technology companies typically implement a higher authorized shares threshold at the time of an initial public offering, which we estimate to average over 2,600,000,000 shares.
• Life360's request for 500,000,000 authorized shares represents less than 1/5th of the average number of authorized shares for other newly public U.S. technology companies.
• Australian incorporated companies listed on the ASX are not subject to a share count limit, giving their boards blanket authority to issue new shares.

Stakeholder Impact

• Shareholders may experience dilution if the U.S. IPO proceeds with a significant primary issuance.
• Employees may benefit from increased equity incentives if the share increase is approved.
• The company's ability to pursue strategic acquisitions and partnerships could be affected by the outcome of the vote on the share increase.

Next Steps

• Stockholder vote on Proposal 14 to increase authorized shares.
• Potential filing of a prospectus supplement with the SEC closer to the U.S. IPO.
• Determination of the timing, number of shares, and pricing of the U.S. IPO based on market conditions.

Key Dates

Keywords

U.S. IPO, authorized shares, stockholder approval, Life360, ASX, Nasdaq, dilution, equity incentives, strategic transactions